Specialized post-transcriptional mechanisms of gene expression in quiescence
Specialized post-transcriptional mechanisms of gene expression in quiescence
批准号:
10797199
负责人:
Shobha Vasudevan
金额:
$16.98万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-09 至 2025-03-31
关键词:
BiochemicalCell CycleCell Cycle ArrestCellsCessation of lifeChemicalsCodeDataDevelopmentDiseaseDrug TargetingDrug resistanceEnabling FactorsExtravasationGene ExpressionGenomeGoalsImmuneImmune System DiseasesImmunityInflammationLeukemic CellMalignant NeoplasmsMapsMediatingMedicalMessenger RNAModificationMolecularMutationPatientsPharmaceutical PreparationsPhasePlayProteomeRNARegulationResearchRibosomesRoleSamplingScienceSignal TransductionSiteSmall Nucleolar RNASmall Nucleolar RibonucleoproteinsStressTranslatingTranslationsUntranslated RNAVisionin vivoinsightleukemiaposttranscriptionalprotein complextissue regenerationtranslation factortranslatome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract Specialized post-transcriptional mechanisms of gene expression in quiescence
Vision Quiescence (G0) is an assortment of reversible, cell-cycle arrested phases that permits cells to avoid
death due to harsh conditions. G0 is critical in immunity and cancer, promoting inflammation and adaptations
for disease persistence; however, G0 is poorly understood despite its medical significance. Our studies
uncovered powerful RNA regulators and modifications in G0 cells, revealing inhibition of conventional
translation and its replacement by non-canonical mechanisms to enable specific gene expression for G0 roles
and survival. Based on our data, G0 cells are perpetuated by specialized post-transcriptional mechanisms that
elicit specific gene expression, which maintains the transient arrested state, enables G0 survival in stress
conditions, and retains the ability of G0 cells to re-enter the cell cycle and persist disease. This permits
important G0 functions: drug and immune survival in malignancies like leukemia, immune cell extravasation,
tissue regeneration, and development. The goal of our study is to investigate the distinct post-transcriptional
mechanisms and gene expression in G0 leukemic cells, to understand G0 roles and persistence in disease.
Premise The key finding of our studies is that conventional translation is inhibited by G0 signals and replaced
by non-canonical factors that enable specific expression of genes that are critical for survival. Significantly,
such non-canonical factors alter translation start site selection, expanding the proteome by creating new
frames (PNAS 2014). We identified noncoding RNAs, associated RNA-protein complexes (RNPs), and non-
canonical translation factors that mediate select expression of few immune and cell state regulators in G0
(Molecular Cell 2016). Our data reveal signaling changes that modify RNPs in G0 to enable specific gene
expression, which allowed targeting of drug resistant G0 in disease (Genome Biol. 2020). Our studies indicate
important layers of undiscovered regulation: modification of ribosomes, mRNAs and RNPs and associated
non-canonical translation (Science 2020, Nat. Commun. 2020, Science Adv. 2022). Characterization of G0
post-transcriptional changes, will reveal hidden mechanisms that drive G0 survival for disease persistence.
Directions in the next 5 years First, profiling, purifications, depletions, mutations, and biochemical analyses
of snoRNAs and ribosomes, will map snoRNPs and ribosome modifications, providing insights on changes to
the translation machinery underlying gene expression in G0 survival. Second, modifications on mRNAs,
associated RNPs, non-canonical translation factors, translated targets and unique start sites in G0 will be
identified to uncover the G0 translatome, expanded at the translation frame. Finally, these will be verified in
vivo and in patient samples, to uncover post-transcriptional mechanisms that impact G0 roles and persistence.
Impact These studies will uncover new insights into G0 post-transcriptional mechanisms, provide a map of
ribosome and RNA modifications, and translation frames, and their impact on G0 roles and survival in disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1126/sciadv.abo1304
发表时间:
2022-10-28
期刊:
Science advances
影响因子:
13.6
作者:
[]
通讯作者:
Role of RNA methylation in chemoresistant cancer cells
-
批准号:9896260
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2020
-
负责人:Shobha Vasudevan
-
依托单位:
Role of RNA methylation in chemoresistant cancer cells
-
批准号:10083714
-
项目类别:
-
资助金额:$19.26万
-
财政年份:2020
-
负责人:Shobha Vasudevan
-
依托单位:
Specialized post-transcriptional mechanisms of gene expression in quiescence
-
批准号:10187599
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Shobha Vasudevan
-
依托单位:
Specialized post-transcriptional mechanisms of gene expression in quiescence
-
批准号:10370377
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Shobha Vasudevan
-
依托单位:
Specialized post-transcriptional mechanisms of gene expression in quiescence
-
批准号:10594054
-
项目类别:
-
资助金额:$41.82万
-
财政年份:2020
-
负责人:Shobha Vasudevan
-
依托单位:
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP
-
批准号:9412472
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2015
-
负责人:Shobha Vasudevan
-
依托单位:
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP
-
批准号:8818264
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2015
-
负责人:Shobha Vasudevan
-
依托单位:
海外基金